menu
    • menu

    Company profile for Vividion Therapeutics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vividion Therapeutics is transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. We are advancing a broad, diversified pipeline of selective small molecule therapeutics for multiple highly sought-after disease-modifying target proteins in oncology and immunology. We are focused on the discovery, development and consolidation of unpr...
    Vividion Therapeutics is transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. We are advancing a broad, diversified pipeline of selective small molecule therapeutics for multiple highly sought-after disease-modifying target proteins in oncology and immunology. We are focused on the discovery, development and consolidation of unprecedented insights and approaches to create small molecule medicines against the most sought-after targets in oncology and immunology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vividion TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5820 Nancy Ridge Drive San Diego, CA 92121
    Telephone
    Telephone
    858.345.4690
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vividion.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vividion Unveils First-in-Class KEAP1 Activator for Oncology
    Vividion Unveils First-in-Class KEAP1 Activator for Oncology

    22 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251222362539/en/Vividion-Publishes-Discovery-of-First-in-Class-KEAP1-Activator-Supporting-Ongoing-Clinical-Program-in-Oncology

    BUSINESSWIRE
    22 Dec 2025
    Share Share
    Bayer Bails On Vividion Tumor Drug In Early-Stage Clear-Out
    Bayer Bails On Vividion Tumor Drug In Early-Stage Clear-Out

    12 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bayer-bails-vividion-tumor-drug-part-early-stage-cancer-clear-out

    FIERCE BIOTECH
    12 Nov 2025
    Share Share
    Vividion Publishes RAS-PI3K Data Showing Block Tumor Growth
    Vividion Publishes RAS-PI3K Data Showing Block Tumor Growth

    09 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251009963422/en/Vividion-Announces-Publication-in-Science-of-Preclinical-Data-on-Covalent-Inhibitors-of-RAS-PI3K-that-Block-Tumor-Growth

    BUSINESSWIRE
    09 Oct 2025
    Share Share
    Vividion Therapeutics Names Sam Whiting as Chief Medical Officer
    Vividion Therapeutics Names Sam Whiting as Chief Medical Officer

    13 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250813751175/en/Vividion-Therapeutics-Appoints-Sam-Whiting-M.D.-Ph.D.-as-Chief-Medical-Officer

    BUSINESSWIRE
    13 Aug 2025
    Share Share
    Vividion, Bayer Advance Clinical WRN Inhibitor for Oncology
    Vividion, Bayer Advance Clinical WRN Inhibitor for Oncology

    04 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250604147547/en/Vividion-Therapeutics-and-Bayer-Further-Strengthen-Oncology-Development-Pipeline-with-Clinical-Stage-WRN-Inhibitor

    BUSINESSWIRE
    04 Jun 2025
    Share Share
    Vividion secures clinical-stage WRN inhibitor from Roche
    Vividion secures clinical-stage WRN inhibitor from Roche

    04 Jun 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bayers-vividion-secures-rights-worlds-only-clinical-stage-wrn-inhibitor-partner-roche

    FIERCE BIOTECH
    04 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search